-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
-
Summary
-
NeuroSense Therapeutics Ltd. quarterly Liabilities and Equity history and growth rate from Q4 2022 to Q2 2024.
- NeuroSense Therapeutics Ltd. Liabilities and Equity for the quarter ending June 30, 2024 was $1.84M.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)